This study revealed inconsistency in documentation of intraoperative management of T1DM, which happens to be a responsibility of the anesthesia provider. Because of the poor documentation, it is difficult to draw conclusion about how anesthesia providers feel about the presence of CSII therapy during the perioperative period or how it is managed. The sample population was small and the outcomes of this study are a possibly a reflection of an institutions attitude toward management of T1DM and CSII therapy. Further studies should not include a retrospective approach, but instead a prospective approach so that outcomes may be observed.
This study revealed inconsistency in documentation of intraoperative management of T1DM, which happens to be a responsibility of the anesthesia provider. Because of the poor documentation, it is difficult to draw conclusion about how anesthesia providers feel about the presence of CSII therapy during the perioperative period or how it is managed. The sample population was small and the outcomes of this study are a possibly a reflection of an institutions attitude toward management of T1DM and CSII therapy. Further studies should not include a retrospective approach, but instead a prospective approach so that outcomes may be observed.
Continuous-Subcutaneous-Insulin-Infusion-Pumps-in-the-Perioperative-Period.docx